Ethyl 2-(2,3,4-trimethoxy-6-octanoylphenyl)acetate

Catalog No. :
ACLIVM309
CAS No. :
1258275-73-8
Molecular Formula :
C21H32O6
Molecular Weight :
380.48

IUPAC Name:ethyl 2-(2,3,4-trimethoxy-6-octanoylphenyl)acetate

Ethyl 2-(2,3,4-trimethoxy-6-octanoylphenyl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
2mg98%$152.00Login to see priceInquiryInquiry
5mg98%$277.00Login to see priceInquiryInquiry
10mg98%$450.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(2,3,4-trimethoxy-6-octanoylphenyl)acetate
IUPAC Nameethyl 2-(2,3,4-trimethoxy-6-octanoylphenyl)acetate
MDL No.MFCD28160842
Molecular FormulaC21H32O6
Molecular Weight380.48
SMILESO=C(OCC)CC1=C(C(CCCCCCC)=O)C=C(OC)C(OC)=C1OC
InChI KeyWCYMJQXRLIDSAQ-UHFFFAOYSA-N
SynonymBenzeneacetic acid, 2,3,4-triMethoxy-6-(1-oxooctyl)-, ethyl ester;Ethyl (2,3,4-trimethoxy-6-octanoylphenyl)acetate;(-)-Prangeferol;Ethyl 2-(2,3,4-trimethoxy-6-octanoylphenyl)acetate;TMPA, 10 mM in DMSO
CAS No.1258275-73-8
PubChem CID60146245

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACLIVM309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLIVM309 route product structure diagram
    ACLIVM3091258275-73-8
Inquiry

2. ACLIVM309 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLIVM309 route product structure diagram
    ACLIVM3091258275-73-8
Inquiry

Comments (0)